Cargando…
Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805679/ http://dx.doi.org/10.1371/annotation/67550546-cacf-4063-8d62-d165da14ca61 |
_version_ | 1782477898220830720 |
---|---|
author | Dieye, Tandakha N. NDiaye, Birahim P. Dieng, Alle B. Fall, Marema Brittain, Nathaniel Vermaak, Samantha Camara, Makhtar Diop-Ndiaye, Halimatou Ngom-Gueye, Ndeye Fatou Diaw, Papa A. Toure-Kane, Coumba Sow, Papa S. Mboup, Souleymane McShane, Helen |
author_facet | Dieye, Tandakha N. NDiaye, Birahim P. Dieng, Alle B. Fall, Marema Brittain, Nathaniel Vermaak, Samantha Camara, Makhtar Diop-Ndiaye, Halimatou Ngom-Gueye, Ndeye Fatou Diaw, Papa A. Toure-Kane, Coumba Sow, Papa S. Mboup, Souleymane McShane, Helen |
author_sort | Dieye, Tandakha N. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3805679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38056792013-11-07 Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects Dieye, Tandakha N. NDiaye, Birahim P. Dieng, Alle B. Fall, Marema Brittain, Nathaniel Vermaak, Samantha Camara, Makhtar Diop-Ndiaye, Halimatou Ngom-Gueye, Ndeye Fatou Diaw, Papa A. Toure-Kane, Coumba Sow, Papa S. Mboup, Souleymane McShane, Helen PLoS One Correction Public Library of Science 2013-10-15 /pmc/articles/PMC3805679/ http://dx.doi.org/10.1371/annotation/67550546-cacf-4063-8d62-d165da14ca61 Text en © 2013 Public Library of Science http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Correction Dieye, Tandakha N. NDiaye, Birahim P. Dieng, Alle B. Fall, Marema Brittain, Nathaniel Vermaak, Samantha Camara, Makhtar Diop-Ndiaye, Halimatou Ngom-Gueye, Ndeye Fatou Diaw, Papa A. Toure-Kane, Coumba Sow, Papa S. Mboup, Souleymane McShane, Helen Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects |
title | Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects |
title_full | Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects |
title_fullStr | Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects |
title_full_unstemmed | Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects |
title_short | Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects |
title_sort | correction: two doses of candidate tb vaccine mva85a in antiretroviral therapy (art) naïve subjects gives comparable immunogenicity to one dose in art+ subjects |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805679/ http://dx.doi.org/10.1371/annotation/67550546-cacf-4063-8d62-d165da14ca61 |
work_keys_str_mv | AT dieyetandakhan correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT ndiayebirahimp correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT diengalleb correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT fallmarema correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT brittainnathaniel correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT vermaaksamantha correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT camaramakhtar correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT diopndiayehalimatou correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT ngomgueyendeyefatou correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT diawpapaa correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT tourekanecoumba correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT sowpapas correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT mboupsouleymane correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects AT mcshanehelen correctiontwodosesofcandidatetbvaccinemva85ainantiretroviraltherapyartnaivesubjectsgivescomparableimmunogenicitytoonedoseinartsubjects |